SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001326110-23-000076
Filing Date
2023-06-14
Accepted
2023-06-14 17:15:06
Documents
13
Period of Report
2023-06-13
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K ibrx-20230613.htm   iXBRL 8-K 61014
2 EX-10.1 ibrx-2023613x8kexhibit101.htm EX-10.1 53690
  Complete submission text file 0001326110-23-000076.txt   265884

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT ibrx-20230613.xsd EX-101.SCH 1985
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT ibrx-20230613_lab.xml EX-101.LAB 24130
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT ibrx-20230613_pre.xml EX-101.PRE 12585
7 EXTRACTED XBRL INSTANCE DOCUMENT ibrx-20230613_htm.xml XML 10849
Mailing Address 3530 JOHN HOPKINS COURT SAN DIEGO CA 92121
Business Address 3530 JOHN HOPKINS COURT SAN DIEGO CA 92121 (844) 696-5235
ImmunityBio, Inc. (Filer) CIK: 0001326110 (see all company filings)

IRS No.: 431979754 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37507 | Film No.: 231015008
SIC: 2836 Biological Products, (No Diagnostic Substances)